The National Institutes of Health has granted Second Sight Medical Products a $1.6 million grant in order to fund the early feasibility clinical trial of a visual cortical prosthesis, the company announced in a press release.
The grant includes an intent to fund $6.3 million over 5 years, which is subject to annual review, the release said.
Funding will go toward clinical testing of five subjects implanted with the Orion cortical visual prosthesis, “which is intended to provide useful artificial vision to individuals who are blind due to various causes,” (Read more...)
Uncategorized